This invention relates to monitoring systems adapted for continuously or at least regularly monitoring the vital signs of a subject, and particularly to a system for measuring blood pressure.
In all developed countries, cardio-vascular diseases like myocardial infarction, congestive heart failure or hypertension have an increasing impact on mortality and morbidity. There is an increasing demand for long term continuous monitoring of a patient's vital signs, which offers the opportunity to evaluate the performance of the cardio-vascular system. Various different blood pressure measurement systems have commonly been used in the past, which require a pressurised cuff or similar device which must be specially attached to the patient when a measurement is to be taken, and also require a suitably skilled clinician to operate them. Consequently such devices are usually confined to uses in a doctor's premises or in hospital, for example, and are not adapted for continuous or regular monitoring purposes.
Accordingly the present invention seeks to provide a blood pressure measuring system, which utilises Pulse Transit Time methodology for deriving measurements from detected signals such as the ECG, and can also be used for monitoring other vital signs. It is particularly suitable for implementation in a continuously wearable undergarment with integrated measuring sensors or electrodes, so as to be directly in contact with the subject's skin. Preferably the garment includes at least four electrodes in order to allow PTT measurements to be made without additional connections to the patient's body.
Preferably the sensors are of a type which do not require special attachment systems, gels or pastes to make proper electrical contact, for example they may be dry electrodes of a type recently developed, made from conductive rubber, which rely only on naturally-produced sweat to make a conductive bridge between the skin and the electrode. Preferably, the undergarment comprises underpants having electrodes arranged internally, at least in the waistband area.
Preferably, electrodes are so arranged as to measure the passing of pulses of the central artery, and the left and right femoralis, as well as the ECG. The system may also be arranged to monitor the temperature, the posture and the level of activity of the subject.
Preferably, pulse detection is achieved using bio-impedance methodology, by injecting a small AC current using a first pair of electrodes, and detecting voltage changes caused by the injected current, with a second pair of electrodes so as to produce an impedance plethysmogram. The preferred arrangement of the electrodes is such that it is possible to measure the plethysmogram of the central aorta, as well as the left and right femoralis. At the same time, it is also possible to measure the ECG, using the dry electrodes in the waistband.
Some embodiments of the invention will now be described by way of example, with reference to the accompanying drawings, in which:
The present invention proposes to use pulse wave velocity methodology, as a means of measuring vital parameters.
Pulse wave velocity (PWV) methodology is a suitable approach for monitoring mechanical parameters, but requires a set of at least two sensors distributed around the body. For instance recent research has confirmed a good correlation between the blood pressure BP and the velocity of pulse wave (PWV). After calibration e.g. via a blood pressure reference measurement with a cuff this technique allows a beat-to-beat determination of BP. Typically a relation of blood pressure and PWV in arteries is expressed by the Moens-Korteweg-relation, which can be derived from hydrodynamic theory:
where: c=pulse wave velocity, Et=tangential elasticity module, ρ=density,
R=radius of artery, h=artery wall thickness.
The experimentally verified relation:
E=E0eαP, α≈0.017 mmHg−1
Provides the link between the PWV and blood pressure (P) variations. The calibration step is necessary to scale the PWV to BP conversion, the other parameters (α, E0, h, r) being clearly subject-dependent and quite difficult to measure directly.
The PWV can be determined by measuring the time of a pressure wave travelling a certain distance in the arterial system in various ways (this time will be called pulse transit time PTT) e.g.:
1. The time-difference of a pulse passing two points at a distance d.
2. The time-difference between the R-peak in ECG-signal and a passing pulse in an artery at a certain body position.
Typical set-ups in the literature are:
1. ECG—and Photoplethysmography PPG; PTT is given by time-difference between R-peak and characteristic points in PPG. The PPG can be measured at various positions on the body e.g. ear or finger.
2. ECG and bio-impedance measurement at arm (impedance plethysmography IPG); PTT is given by the time-difference between R-peak and characteristic points in the IPG.
3. Impedance Cardiography (ICG) of the thorax and bio-impedance measurement at arm (IPG); PTT is given by the time-difference between characteristic points in the ICG and characteristic points in the IPG.
4. Impedance plethysmogram (IPG1) at a first position on an arm and bio-impedance measurement at a second position on an arm (IPG2); PTT is given by the time-difference between characteristic points in the IPG1 and characteristic points in the IPG2.
If clinical standard sensors or methodologies are used, all these methods have several disadvantages especially for Personal Healthcare applications. State of the art sensors such as finger or ear sensors measuring a photoplethysmogram or bio-impedance methodologies are rather an inconvenience in normal life requiring finger and ear PPG sensors or special medical electrodes, which must be glued to the skin. Therefore such state-of-the-art sensors are not suitable for long term continuous monitoring in Personal Healthcare applications.
The general principle of bio-impedance measurements is illustrated by the diagram of
A further pair of electrodes 6 are then used to detect voltage changes caused by the exciting current, which are a measure of the variation in impedance caused by changes in blood volume and velocity. This enables the arterial volume pulsation to be measured, via a control/measuring circuit 8.
It will be appreciated that the same principle can be applied to measurements made in other regions of the body, and the present invention therefore proposes to make measurements in the region of the subject's waist, as indicated at 10 in the schematic of
Further electrodes 26 and 28 are arranged respectively at the right and left leg positions, and in this way, for example, a current I2 can be injected between the corresponding waistband electrode 22 and the right leg electrode 26, to enable a voltage V2 to be measured, relative to the waistband position, at an electrode 30. Similarly, by injecting a current I3 between a left leg electrode 28 and the corresponding waistband electrode 22, a voltage V3 can be measured, relative to the waistband, at an electrode 32.
A power supply 44, which preferably incorporates long-life or rechargeable batteries, is provided for powering the unit, and a RF transceiver 46 enables the device to communicate data with external systems, such as a user interface. Storage means 48, for example a flash memory, is also incorporated to allow data to be stored or buffered whenever necessary. In this way the device can also be employed as a “Holter monitor” (ambulatory electrocardiography device) so as to record cardiac activity over an extended period of time.
Accordingly, it will be appreciated that the system of the invention allows the following different measurements to be taken:
Measured Signals:
Number | Date | Country | Kind |
---|---|---|---|
06116624.5 | Jul 2006 | EP | regional |
06116930.6 | Jul 2007 | EP | regional |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB07/52512 | 6/28/2007 | WO | 00 | 12/22/2008 |